Abstract
An institutional investigation was conducted at the request of the Oncotarget editorial staff by the Academia Sinica Ethics Committee (Taipei, Taiwan). The Committee concluded the following: "The partial duplication of Figure 4a and 4b is judged to be a mistake during data processing, rather than a research misconduct." The correct Figure 4B is shown below; 4A appears correctly in the original article. The authors declare that these corrections do not change the results or conclusions of this paper.
Original language | English |
---|---|
Pages (from-to) | 32271 |
Number of pages | 1 |
Journal | Oncotarget |
Volume | 9 |
Issue number | 63 |
DOIs |
|
Publication status | Published - Aug 14 2018 |
Fingerprint
ASJC Scopus subject areas
- Oncology
Cite this
Correction : Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1 [Oncotarget, 7 (2016) (43629-43653)] Doi: 10.18632/oncotarget.9660. / Yin, Shu Yi; Efferth, Thomas; Jian, Feng Yin; Chen, Yung Hsiang; Liu, Chia I.; Wang, Andrew H.J.; Chen, Yet Ran; Hsiao, Pei Wen; Yang, Ning Sun.
In: Oncotarget, Vol. 9, No. 63, 14.08.2018, p. 32271.Research output: Contribution to journal › Comment/debate
}
TY - JOUR
T1 - Correction
T2 - Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1 [Oncotarget, 7 (2016) (43629-43653)] Doi: 10.18632/oncotarget.9660
AU - Yin, Shu Yi
AU - Efferth, Thomas
AU - Jian, Feng Yin
AU - Chen, Yung Hsiang
AU - Liu, Chia I.
AU - Wang, Andrew H.J.
AU - Chen, Yet Ran
AU - Hsiao, Pei Wen
AU - Yang, Ning Sun
PY - 2018/8/14
Y1 - 2018/8/14
N2 - An institutional investigation was conducted at the request of the Oncotarget editorial staff by the Academia Sinica Ethics Committee (Taipei, Taiwan). The Committee concluded the following: "The partial duplication of Figure 4a and 4b is judged to be a mistake during data processing, rather than a research misconduct." The correct Figure 4B is shown below; 4A appears correctly in the original article. The authors declare that these corrections do not change the results or conclusions of this paper.
AB - An institutional investigation was conducted at the request of the Oncotarget editorial staff by the Academia Sinica Ethics Committee (Taipei, Taiwan). The Committee concluded the following: "The partial duplication of Figure 4a and 4b is judged to be a mistake during data processing, rather than a research misconduct." The correct Figure 4B is shown below; 4A appears correctly in the original article. The authors declare that these corrections do not change the results or conclusions of this paper.
UR - http://www.scopus.com/inward/record.url?scp=85051589947&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051589947&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.26007
DO - 10.18632/oncotarget.26007
M3 - Comment/debate
AN - SCOPUS:85051589947
VL - 9
SP - 32271
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 63
ER -